Key dangers include: Overdose or underdose: Errors in calculation can result in receiving far more or far less than the intended amount, leading to severe adverse effects or no therapeutic benefit Microbial contamination: Without pharmaceutical-grade manufacturing conditions, vials may be contaminated with bacteria or fungi, risking serious infection including sepsis Chemical degradation: Improper storage, incorrect diluent, or excessive agitation can degrade the peptide, producing unknown breakdown products Injection site complications: Subcutaneous injections performed without training can cause lipodystrophy, abscess formation, or nerve injury There is also a psychological dimension to consider
Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. The Journal of pharmacology and experimental therapeutics vol
Li C, Deng D, Jiang Q, Shi J, Xu L, Liu Y
At the time of writing, GHK-Cu is available to researchers as a reference material for in vitro experimentation only